FierceBiotech's 2015 Fierce 15

Whatever lies ahead for biotech in 2016, we can now look back on a 3-year-long stretch of good times for the industry. Venture groups have used the wave of biotech IPO exits and M&A deals to go back and raise more money from institutional investors. And as billions of dollars in fresh capital has converged with brilliant new scientific thinking, the result is a whole new wave of standout innovators as represented here by the Fierce 15.

Most Recent Posts:

Innovation Grand Rounds: Investing in your Home-Grown Innovations

Innovation Grand Rounds is a monthly live series with talks by innovators and executives from across the…

Read More

Four Brigham Ignite Awards Announced

Innovations focus on CT-guided neurosurgery, knee osteoarthritis, brain tumors, and C-sections   BOSTON, MA – September 7,…

Read More

Artificial Intelligence Model Outperforms Clinicians in Diagnosing Pediatric Ear Infections

In collaboration with Mass General Brigham Innovation, OtoDx is currently being employed in a prototype device paired…

Read More